Brief: Tepoxx Approved In Japan For The Treatment Of Orthopoxviruses
02/01/2025 14:21
Jan 2 (Reuters) - SIGA Technologies Inc SIGA.O :
* TEPOXX (TECOVIRIMAT) APPROVED IN JAPAN FOR THE TREATMENT
OF
ORTHOPOXVIRUSES
* SIGA TECHNOLOGIES INC - JAPAN BIOTECHNO PHARMA TO SUPPLY
TEPOXX
TO NATIONAL STOCKPILE
Source text: ID:nGNX6lJ52k
Further company coverage: SIGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA